Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL0800001	人源抗-TNFα单克隆抗体(CNTO148)注射剂	golimumab	Injection	Biological Products(1)	Import Drug Application	2008-01-15	西安杨森制药有限公司	Xian Janssen Pharmaceutical Ltd	Certificate Issued	2009-04-08	view
JXSL1000057	人源抗-TNFα单克隆抗体(CNTO 148)注射剂	golimumab	Injection	Biological Products	Import Drug Application	2010-12-17	Centocor B.V.	Centocor BV	Certificate Issued	2013-11-15	view
JXSL1200051	戈利木单抗注射液	golimumab	Injection	Biological Products	Import Drug Application	2012-07-09	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2014-07-24	view
JXSL1500061	戈利木单抗静脉注射液	golimumab	Injection	Biological Products	Import Drug Application	2015-10-28	JANSSEN INC.	Janssen Inc	Certificate Issued	2017-05-11	view
JXSL2200034	戈利木单抗注射液	golimumab	Injection	Biological Products(2.2)	Import Drug Application	2022-03-22					view
JXSL2300107	戈利木单抗注射液	golimumab	Injection	Biological Products(2.2)	Import Drug Application	2023-06-16					view
JXSR1400001	戈利木单抗注射液	golimumab	Injection	Biological Products	State Standards	2014-09-25	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2018-04-25	view
JXSS1400007	CNTO 148单抗注射液	golimumab	Injection	Biological Products	Import Drug Application	2014-07-17	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2018-01-04	view
JYSB1800033	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2018-03-02	Janssen Biologics B.V.	Janssen Biologics BV	Filed	2018-03-18	view
JYSB1800120	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2018-06-04	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2018-07-26	view
JYSB1800200	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2018-09-29	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2019-05-06	view
JYSB1900115	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2019-06-03	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2020-02-27	view
JYSB1900121	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2019-05-31	Janssen Biologics B.V.	Janssen Biologics BV	Filed	2019-06-11	view
JYSB1900231	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2019-09-04	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2020-08-18	view
JYSB2000334	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2020-06-28	Janssen Biologics B.V.	Janssen Biologics BV	Filed	2020-07-01	view
JYSB2000678	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2020-12-28	西安杨森制药有限公司	Xian Janssen Pharmaceutical Ltd	Certificate Issued	2021-12-17	view
JYSB2000679	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2020-12-28	Janssen Biologics B.V.	Janssen Biologics BV	In Review	2022-01-27	view
JYSB2100062	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2021-02-26	西安杨森制药有限公司	Xian Janssen Pharmaceutical Ltd	Certificate Issued	2021-12-24	view
JYSB2100063	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2021-02-26	西安杨森制药有限公司	Xian Janssen Pharmaceutical Ltd	Certificate Issued	2021-12-24	view
JYSB2100089	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2021-04-01	Janssen Biologics B.V.	Janssen Biologics BV	In Review	2021-05-09	view